Drusen secondary to age-related macular degeneration

Karen B. Schaal, Philip J Rosenfeld

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Drusen are one of the earliest signs of age-related macular degeneration (AMD) and are important for assessing disease progression and for the staging of disease severity. SD-OCT imaging is currently the most reliable strategy for following drusen morphology and progression over time, and SD-OCT imaging has replaced color fundus imaging for following drusen in clinical trials. The SD-OCT algorithm used to measure drusen defines drusen as elevations of the overlying RPE and provides both area and volume measurements. Drusen volume was found to be a more sensitive indicator of drusen growth compared with area measurements and offers an opportunity to study therapies at an earlier stage of AMD. By intervening earlier, there’s the potential to preserve better vision over a lifetime. An ideal baseline drusen volume to study in clinical trials was found to be a drusen volume of at least 0.03 mm3 (cube root volume 0.31 mm), which is easily measured by SD-OCT imaging and includes the large drusen (125 µm) that are easily seen on color fundus imaging. To determine if drusen actually grow or decrease in size, we recommend the use of the difference in cube-root of the volume measurements to evaluate the change in drusen over time.

Original languageEnglish (US)
Title of host publicationSpectral Domain Optical Coherence Tomography in Macular Diseases
PublisherSpringer India
Pages159-167
Number of pages9
ISBN (Electronic)9788132236108
ISBN (Print)9788132236085
DOIs
StatePublished - Jan 1 2016

Fingerprint

Macular Degeneration
Color
Clinical Trials
Disease Progression
Growth
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schaal, K. B., & Rosenfeld, P. J. (2016). Drusen secondary to age-related macular degeneration. In Spectral Domain Optical Coherence Tomography in Macular Diseases (pp. 159-167). Springer India. https://doi.org/10.1007/978-81-322-3610-8_13

Drusen secondary to age-related macular degeneration. / Schaal, Karen B.; Rosenfeld, Philip J.

Spectral Domain Optical Coherence Tomography in Macular Diseases. Springer India, 2016. p. 159-167.

Research output: Chapter in Book/Report/Conference proceedingChapter

Schaal, KB & Rosenfeld, PJ 2016, Drusen secondary to age-related macular degeneration. in Spectral Domain Optical Coherence Tomography in Macular Diseases. Springer India, pp. 159-167. https://doi.org/10.1007/978-81-322-3610-8_13
Schaal KB, Rosenfeld PJ. Drusen secondary to age-related macular degeneration. In Spectral Domain Optical Coherence Tomography in Macular Diseases. Springer India. 2016. p. 159-167 https://doi.org/10.1007/978-81-322-3610-8_13
Schaal, Karen B. ; Rosenfeld, Philip J. / Drusen secondary to age-related macular degeneration. Spectral Domain Optical Coherence Tomography in Macular Diseases. Springer India, 2016. pp. 159-167
@inbook{dfceaa8168f442238ee050c4424fe935,
title = "Drusen secondary to age-related macular degeneration",
abstract = "Drusen are one of the earliest signs of age-related macular degeneration (AMD) and are important for assessing disease progression and for the staging of disease severity. SD-OCT imaging is currently the most reliable strategy for following drusen morphology and progression over time, and SD-OCT imaging has replaced color fundus imaging for following drusen in clinical trials. The SD-OCT algorithm used to measure drusen defines drusen as elevations of the overlying RPE and provides both area and volume measurements. Drusen volume was found to be a more sensitive indicator of drusen growth compared with area measurements and offers an opportunity to study therapies at an earlier stage of AMD. By intervening earlier, there’s the potential to preserve better vision over a lifetime. An ideal baseline drusen volume to study in clinical trials was found to be a drusen volume of at least 0.03 mm3 (cube root volume 0.31 mm), which is easily measured by SD-OCT imaging and includes the large drusen (125 µm) that are easily seen on color fundus imaging. To determine if drusen actually grow or decrease in size, we recommend the use of the difference in cube-root of the volume measurements to evaluate the change in drusen over time.",
author = "Schaal, {Karen B.} and Rosenfeld, {Philip J}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-81-322-3610-8_13",
language = "English (US)",
isbn = "9788132236085",
pages = "159--167",
booktitle = "Spectral Domain Optical Coherence Tomography in Macular Diseases",
publisher = "Springer India",
address = "India",

}

TY - CHAP

T1 - Drusen secondary to age-related macular degeneration

AU - Schaal, Karen B.

AU - Rosenfeld, Philip J

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Drusen are one of the earliest signs of age-related macular degeneration (AMD) and are important for assessing disease progression and for the staging of disease severity. SD-OCT imaging is currently the most reliable strategy for following drusen morphology and progression over time, and SD-OCT imaging has replaced color fundus imaging for following drusen in clinical trials. The SD-OCT algorithm used to measure drusen defines drusen as elevations of the overlying RPE and provides both area and volume measurements. Drusen volume was found to be a more sensitive indicator of drusen growth compared with area measurements and offers an opportunity to study therapies at an earlier stage of AMD. By intervening earlier, there’s the potential to preserve better vision over a lifetime. An ideal baseline drusen volume to study in clinical trials was found to be a drusen volume of at least 0.03 mm3 (cube root volume 0.31 mm), which is easily measured by SD-OCT imaging and includes the large drusen (125 µm) that are easily seen on color fundus imaging. To determine if drusen actually grow or decrease in size, we recommend the use of the difference in cube-root of the volume measurements to evaluate the change in drusen over time.

AB - Drusen are one of the earliest signs of age-related macular degeneration (AMD) and are important for assessing disease progression and for the staging of disease severity. SD-OCT imaging is currently the most reliable strategy for following drusen morphology and progression over time, and SD-OCT imaging has replaced color fundus imaging for following drusen in clinical trials. The SD-OCT algorithm used to measure drusen defines drusen as elevations of the overlying RPE and provides both area and volume measurements. Drusen volume was found to be a more sensitive indicator of drusen growth compared with area measurements and offers an opportunity to study therapies at an earlier stage of AMD. By intervening earlier, there’s the potential to preserve better vision over a lifetime. An ideal baseline drusen volume to study in clinical trials was found to be a drusen volume of at least 0.03 mm3 (cube root volume 0.31 mm), which is easily measured by SD-OCT imaging and includes the large drusen (125 µm) that are easily seen on color fundus imaging. To determine if drusen actually grow or decrease in size, we recommend the use of the difference in cube-root of the volume measurements to evaluate the change in drusen over time.

UR - http://www.scopus.com/inward/record.url?scp=85018547326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018547326&partnerID=8YFLogxK

U2 - 10.1007/978-81-322-3610-8_13

DO - 10.1007/978-81-322-3610-8_13

M3 - Chapter

SN - 9788132236085

SP - 159

EP - 167

BT - Spectral Domain Optical Coherence Tomography in Macular Diseases

PB - Springer India

ER -